Immunodiagnostic Systems Holdings (United Kingdom)
Corporate brand
UnclaimedIDS PLC is an in-vitro diagnostic solution provider to clinical and research laboratory markets, now visibly part of Euroimmun.
Last updated September 16, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Immunodiagnostic Systems Holdings (United Kingdom), trading as IDS PLC, describes itself as the leading in-vitro diagnostic solution provider to the clinical and research laboratory markets. With over 30 years of expertise, it develops in-house, manufactures and markets immunoassays and instruments. Its portfolio includes random-access automation solutions, chemiluminescence immunoassays and ELISAs for endocrinology, autoimmunity, animal research, allergy, infectious diseases and therapeutic drug monitoring. The company states it has more than 300 employees worldwide. Its website indicates it is now visibly part of Euroimmun, with a unified visual identity reflecting that integration.
History
IDS PLC states it has over 30 years of expertise in developing, manufacturing and marketing immunoassays and instruments. Its website indicates it is now visibly part of Euroimmun, with a modern new look reflecting that integration and a unified visual identity. The company describes itself as the leading in-vitro diagnostic solution provider to the clinical and research laboratory markets, with more than 300 employees worldwide developing and distributing random-access automation solutions, chemiluminescence immunoassays and ELISAs.
Products and positioning
Leading in-vitro diagnostic solution provider to the clinical and research laboratory markets.
IDS-iSYS Multi-Discipline Automated System
Fully automated system that enhances laboratory efficiency and productivity.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/immunodiagnostic-systems-holdings-united-kingdom · Editorial policy · How profiles are compiled